Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 3935.75 | 89 / 89 | 98% | 142.05 | 885 / 901 |
breast | 100% | 12204.85 | 458 / 459 | 94% | 100.75 | 1048 / 1118 |
brain | 95% | 7141.82 | 2519 / 2642 | 95% | 82.92 | 673 / 705 |
thymus | 99% | 2658.19 | 646 / 653 | 90% | 91.72 | 543 / 605 |
adrenal gland | 98% | 2495.46 | 252 / 258 | 88% | 43.96 | 202 / 230 |
ovary | 100% | 4739.77 | 180 / 180 | 79% | 34.10 | 341 / 430 |
liver | 97% | 3391.61 | 219 / 226 | 80% | 41.69 | 325 / 406 |
lung | 97% | 3069.36 | 563 / 578 | 68% | 45.50 | 786 / 1155 |
stomach | 86% | 1687.59 | 307 / 359 | 78% | 39.88 | 224 / 286 |
intestine | 78% | 1884.61 | 754 / 966 | 80% | 45.72 | 420 / 527 |
prostate | 66% | 1178.21 | 161 / 245 | 80% | 31.41 | 403 / 502 |
pancreas | 51% | 770.59 | 168 / 328 | 93% | 104.48 | 165 / 178 |
bladder | 76% | 1923.38 | 16 / 21 | 60% | 47.82 | 300 / 504 |
esophagus | 63% | 1758.19 | 912 / 1445 | 54% | 35.12 | 98 / 183 |
uterus | 64% | 1069.80 | 108 / 170 | 44% | 23.79 | 202 / 459 |
adipose | 100% | 13500.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 4283.24 | 799 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 3115.51 | 1314 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 4299.95 | 823 / 861 | 0% | 0 | 0 / 0 |
skin | 20% | 327.73 | 358 / 1809 | 68% | 29.51 | 322 / 472 |
eye | 0% | 0 | 0 / 0 | 81% | 33.06 | 65 / 80 |
lymph node | 0% | 0 | 0 / 0 | 62% | 15.46 | 18 / 29 |
spleen | 59% | 867.39 | 142 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 9% | 157.90 | 82 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 1.05 | 3 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009617 | Biological process | response to bacterium |
GO_0036152 | Biological process | phosphatidylethanolamine acyl-chain remodeling |
GO_0016042 | Biological process | lipid catabolic process |
GO_0008654 | Biological process | phospholipid biosynthetic process |
GO_1903008 | Biological process | organelle disassembly |
GO_0007031 | Biological process | peroxisome organization |
GO_0006641 | Biological process | triglyceride metabolic process |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0070306 | Biological process | lens fiber cell differentiation |
GO_1904177 | Biological process | regulation of adipose tissue development |
GO_0030397 | Biological process | membrane disassembly |
GO_0070292 | Biological process | N-acylphosphatidylethanolamine metabolic process |
GO_0046485 | Biological process | ether lipid metabolic process |
GO_0005778 | Cellular component | peroxisomal membrane |
GO_0005575 | Cellular component | cellular_component |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005764 | Cellular component | lysosome |
GO_0005777 | Cellular component | peroxisome |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0008970 | Molecular function | phospholipase A1 activity |
GO_0052739 | Molecular function | phosphatidylserine 1-acylhydrolase activity |
GO_0052740 | Molecular function | 1-acyl-2-lysophosphatidylserine acylhydrolase activity |
GO_0008289 | Molecular function | lipid binding |
GO_0004623 | Molecular function | phospholipase A2 activity |
GO_0016746 | Molecular function | acyltransferase activity |
GO_0016410 | Molecular function | N-acyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PLAAT3 |
Protein name | Phospholipase A and acyltransferase 3 Phospholipase A and acyltransferase 3 (EC 2.3.1.-) (EC 3.1.1.32) (EC 3.1.1.4) (Adipose-specific phospholipase A2) (AdPLA) (Group XVI phospholipase A1/A2) (H-rev 107 protein homolog) (H-REV107) (HREV107-1) (HRAS-like suppressor 1) (HRAS-like suppressor 3) (HRSL3) (HREV107-3) (Renal carcinoma antigen NY-REN-65) PLA2G16 protein |
Synonyms | HRASLS3 HREV107 PLA2G16 |
Description | FUNCTION: Exhibits both phospholipase A1/2 and acyltransferase activities . Shows phospholipase A1 (PLA1) and A2 (PLA2) activity, catalyzing the calcium-independent release of fatty acids from the sn-1 or sn-2 position of glycerophospholipids . For most substrates, PLA1 activity is much higher than PLA2 activity . Shows O-acyltransferase activity,catalyzing the transfer of a fatty acyl group from glycerophospholipid to the hydroxyl group of lysophospholipid . Shows N-acyltransferase activity, catalyzing the calcium-independent transfer of a fatty acyl group at the sn-1 position of phosphatidylcholine (PC) and other glycerophospholipids to the primary amine of phosphatidylethanolamine (PE), forming N-acylphosphatidylethanolamine (NAPE), which serves as precursor for N-acylethanolamines (NAEs) . Exhibits high N-acyltransferase activity and low phospholipase A1/2 activity . Required for complete organelle rupture and degradation that occur during eye lens terminal differentiation, when fiber cells that compose the lens degrade all membrane-bound organelles in order to provide lens with transparency to allow the passage of light. Organelle membrane degradation is probably catalyzed by the phospholipase activity (By similarity). .; FUNCTION: (Microbial infection) Acts as a host factor for picornaviruses: required during early infection to promote viral genome release into the cytoplasm . May act as a cellular sensor of membrane damage at sites of virus entry, which relocalizes to sites of membrane rupture upon virus unfection . Facilitates safe passage of the RNA away from LGALS8, enabling viral genome translation by host ribosome . May also be involved in initiating pore formation, increasing pore size or in maintaining pores for genome delivery . The lipid-modifying enzyme activity is required for this process . . |
Accessions | P53816 ENST00000540943.1 ENST00000323646.9 ENST00000415826.3 F5H7E5 Q3MI98 |